Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 2 |
Citigroup
C
|
+$374M |
| 3 |
Amazon
AMZN
|
+$352M |
| 4 |
XL
XL Group Ltd.
XL
|
+$284M |
| 5 |
PPG Industries
PPG
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$288M |
| 2 |
Union Pacific
UNP
|
+$283M |
| 3 |
JPMorgan Chase
JPM
|
+$238M |
| 4 |
AGN
Allergan plc
AGN
|
+$226M |
| 5 |
Archer Daniels Midland
ADM
|
+$216M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 8.85% |
| 2 | Financials | 7.52% |
| 3 | Industrials | 6.64% |
| 4 | Energy | 5.78% |
| 5 | Technology | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4351
PUT
Murphy USA
MUSA
$10.5B
| $592K | ﹤0.01% |
8,600
+1,200
| +16% | +$71.2K |
|
4352
PUT
Realty Income
O
$59.4B
| $592K | ﹤0.01% |
12,797
-12,487
| -49% | -$553K |
|
4353
Patrick Industries
PATK
$2.76B
| $591K | ﹤0.01% |
45,343
-38,279
| -46% | -$485K |
|
|
INVX
4354
CALL
Innovex International
INVX
$2.18B
| $591K | ﹤0.01% |
7,700
+1,100
| +17% | +$91.7K |
|
|
INVX
4355
PUT
Innovex International
INVX
$2.18B
| $591K | ﹤0.01% |
7,700
-4,000
| -34% | -$333K |
|
|
DL
4356
DELISTED
China Distance Education Holdings Limited
DL
| $591K | ﹤0.01% |
+36,069
| New | +$563K |
|
|
BMCH
4357
DELISTED
BMC Stock Holdings, Inc
BMCH
| $591K | ﹤0.01% |
+38,542
| New | +$592K |
|
4358
PUT
Hyatt Hotels
H
$17.1B
| $590K | ﹤0.01% |
9,800
+4,500
| +85% | +$264K |
|
4359
CALL
Halozyme
HALO
$11.2B
| $590K | ﹤0.01% |
61,100
+17,000
| +39% | +$151K |
|
4360
Pebblebrook Hotel Trust
PEB
$2.06B
| $590K | ﹤0.01% |
12,930
-33,862
| -72% | -$1.42M |
|
4361
CALL
ResMed
RMD
$32.4B
| $589K | ﹤0.01% |
10,500
-2,700
| -20% | -$141K |
|
|
CLR
4362
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $589K | ﹤0.01% |
15,355
+14,860
| +3,002% | +$732K |
|
4363
Nomura Holdings
NMR
$28.7B
| $588K | ﹤0.01% |
103,734
+92,666
| +837% | +$548K |
|
|
GRUB
4364
CALL
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
| $588K | ﹤0.01% |
8,100
-8,400
| -51% | -$593K |
|
|
SF
4365
CALL
Stifel
SF
$12.9B
| $587K | ﹤0.01% |
25,875
+13,950
| +117% | +$295K |
|
4366
PUT
Fair Isaac
FICO
$23.5B
| $586K | ﹤0.01% |
8,100
-2,100
| -21% | -$138K |
|
4367
PUT
Hecla Mining
HL
$12.3B
| $586K | ﹤0.01% |
210,100
-63,700
| -23% | -$158K |
|
4368
Nu Skin
NUS
$234M
| $586K | ﹤0.01% |
13,408
+10,954
| +446% | +$484K |
|
4369
CALL
Silicon Laboratories
SLAB
$7.29B
| $586K | ﹤0.01% |
12,300
+8,600
| +232% | +$379K |
|
|
ACOR
4370
DELISTED
Acorda Therapeutics
ACOR
| $586K | ﹤0.01% |
120
-755
| -86% | -$3.24M |
|
|
BT
4371
DELISTED
BT Group plc (ADR)
BT
| $586K | ﹤0.01% |
+18,922
| New | +$578K |
|
|
ECYT
4372
DELISTED
Endocyte, Inc. Common Stock
ECYT
| $586K | ﹤0.01% |
93,139
-219,477
| -70% | -$1.34M |
|
4373
Amphastar Pharmaceuticals
AMPH
$889M
| $585K | ﹤0.01% |
50,384
+34,684
| +221% | +$378K |
|
|
ELGX
4374
DELISTED
Endologix Inc
ELGX
| $585K | ﹤0.01% |
3,826
-138,231
| -97% | -$17.3M |
|
|
IRF
4375
DELISTED
INTL RECTIFIER CORP
IRF
| $585K | ﹤0.01% |
14,674
-793,425
| -98% | -$31.5M |
|
Similar funds
Ken Griffin's Q4 2014 Portfolio in Review
As of Q4 2014, Ken Griffin held 9,167 positions worth $102B, up 6.5% from $95.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Ken Griffin's Q4 2014 filing shows 1,076 new, 3,582 increased, 3,580 reduced and 702 closed positions. Its largest new stake was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $288M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 8.8% of assets, up from 7.6% a quarter earlier, followed by Financials and Industrials.
- Ken Griffin's largest Q4 2014 buy was SIGMA - ALDRICH CORP: 1,469,606 shares worth $202M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.04B increase.
- Ken Griffin's biggest Q4 2014 reduction was Union Pacific, cutting an estimated $283M.
- Ken Griffin fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q4 2014, selling an estimated $288M.
- Ken Griffin's ten largest holdings make up 16% of its $102B portfolio in Q4 2014.
- Ken Griffin opened 1,076 new positions and closed 702 in Q4 2014.
- Ken Griffin's portfolio value rose 6.5% quarter-over-quarter to $102B.
Based on Citadel Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.